around.pk
Monday, 16 November 2026
☀ Karachi 27°☀ Lahore 21°☀ Islamabad 16°
Health

Punjab Orders Recall of Five Injectable Medicines After Lab Tests Find Quality Issues

The Directorate of Drugs Control Punjab has directed manufacturers and pharmacies to withdraw specific batches of five injections after laboratory testing flagged substandard or adulterated products.

around.pk·6m ago

The Punjab government has ordered an immediate recall of five injectable medicines after laboratory analysis found certain batches to be substandard or adulterated, according to a public notice issued by the Directorate of Drugs Control on November 13. The Provincial Quality Control Board directed that the affected batches be withdrawn from the market, citing potential risks to patient safety.

Two batches of Injection Dormicum, manufactured by Martin Dow Marker Ltd., were declared substandard after visible particulate matter was detected in the product. Injection Davilax, produced by Unison Chemical Works, was classified as adulterated. Injection Zeftrox, made by Zafa Pharmaceutical Laboratories, was found substandard following sterility testing, while two strengths of Injection PSOL from Pharmasol Private Ltd. were also flagged, one for sterility failure and another for visible particulate matter.

The Directorate has instructed manufacturers and marketing authorization holders to recall the affected batches without delay, submit complete distribution records, carry out root-cause analyses and file Corrective and Preventive Action plans with the relevant regulatory authorities. Pharmacies, medical stores, wholesalers, distributors and healthcare facilities across the province have been told to stop dispensing the affected batches and to report remaining stock and consumption records to their respective Drug Inspectors.

Regulators have also been directed to tighten surveillance of the pharmaceutical supply chain and to take action under the Drugs Act, 1976, and the DRAP Act, 2012. Patients have been urged to stop using the affected batches, with the Directorate warning that continued use could pose health risks.

Healthcare professionals and consumers have been asked to report any related adverse drug reactions to the Provincial Pharmacovigilance Centre at the Directorate of Drugs Control, Punjab. The recall underlines ongoing efforts to monitor medicine quality across the province's pharmaceutical market.

The notice did not specify how widely the affected batches had been distributed, and it was not immediately clear whether any adverse reactions had been reported in connection with the products.

The story so far Punjab

  1. Punjab Food Authority Fines Food Businesses Rs283,000 in Multan Division Crackdown
  2. Bank of Punjab Extends CEO Zafar Masud's Tenure Until 2030
  3. Gallup Pakistan: Khyber Pakhtunkhwa Leads Premium Dry Fruit Purchases
  4. Punjab Government Approves Rs23.85 Billion Khushhal Dehat Program for Rural Infrastructure
See the full timeline →
PunjabDirectorate of Drugs Control PunjabDrugs Act, 1976Injection DormicumMartin Dow Marker Ltd.Pharmasol Private Ltd.Provincial Quality Control Board

Continue the story

View all →

Read more